IP Library Granted Patent US 10,435,730
Granted Patent B2
US 10,435,730 · App. 15/439,660 · Granted Oct 8, 2019

Recombinant production of steviol glycosides

Inventors: Jens Houghton-Larsen (Birkerod, DK); Paula Hicks (Bend, OR); Michael Naesby (Basel, CH); Thomas Tange Ostergaard (Basel, CH); Jorgen Hansen (Frederiksberg, DK); Michael Mikkelsen Dalgaard (Vaerlose, DK); Esben Hansen Halkjaer (Frederiksberg, DK); Ernesto Simon (Copenhagen, DK); Sabina De Andrade Periera Tavares (Basel, CH)
Assignee: EVOLVA SA
C12P19/56C12N9/0032C12N9/0071C12N9/0073C12N9/1051C12N9/1085C12N9/88C12N9/90C12N15/63C12N15/81C12N15/8243C12P19/44Y02P20/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,435,730
App. No.
15/439,660
Granted
Oct 8, 2019
Kind
B2
Abstract

Recombinant microorganisms, plants, and plant cells are disclosed that have been engineered to express recombinant genes encoding UDP-glycosyltransferases (UGTs). Such microorganisms, plants, or plant cells can produce steviol glycosides, e.g., Rebaudioside A and/or Rebaudioside D, which can be used as natural sweeteners in food products and dietary supplements.

Claims (64)

1. A method for producing a target steviol glycoside or a target steviol glycoside composition, comprising contacting a starting composition comprising a steviol, a precursor steviol glycoside having a 13-O-glucose, a 19-O-glucose, or both the 13-O-glucose and the 19-O-glucose, and/or a mixture thereof with a first polypeptide capable of beta 1,2 glycosylation of a C2′ of the 13-O-glucose, the 19-O-glucose, or both the 13-O-glucose and the 19-O-glucose of the precursor steviol glycoside and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:152; and one or more of:

(a) a second polypeptide capable of beta 1,2 glycosylation of the C2′ of the 13-O-glucose, the 19-O-glucose, or both the 13-O-glucose and the 19-O-glucose of the precursor steviol glycoside and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:5;

(b) a polypeptide capable of rhamnosylation of a steviol 13-O-monoside and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:150;

(c) a polypeptide of uridine 5′-diphospho (UDP) glycosyl transferase (UGT) UGT74 family, comprising a UGT74G1 polypeptide capable of glycosylating the steviol or the precursor steviol glycoside at its C-19 carboxyl group and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:1;

(d) a polypeptide of uridine 5′-diphospho (UDP) glycosyl transferase (UGT) UGT85 family, comprising a UGT85C2 polypeptide capable of glycosylating the steviol or the precursor steviol glycoside at its C-13 hydroxyl group and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:3; and/or

(e) a polypeptide capable of beta 1,3 glycosylation of a C3′ of the 13-O-glucose, the 19-O-glucose, or both the 13-O-glucose and the 19-O-glucose of the precursor steviol glycoside and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:7;

wherein at least one of the polypeptides is a recombinant polypeptide;

and one or more UDP-sugars, under suitable reaction conditions for the transfer of one or more sugar moieties from the one or more UDP-sugars to the steviol, the precursor steviol glycoside, and/or the mixture thereof,

thereby producing the target steviol glycoside or the target steviol glycoside composition.

2. The method of claim 1 , wherein the one or more UDP-sugar comprises UDP-glucose, UDP-rhamnose, fructose, and/or UDP-xylose.

3. The method of claim 1 , wherein the target steviol glycoside comprises steviol-1,2-bioside, stevioside, rebaudioside A, rebaudioside B, rebaudioside C, rebaudioside D, rebaudioside E, rebaudioside F, or dulcoside A.

4. The method of claim 1 , wherein the target steviol glycoside composition comprises steviol-1,2-bioside, stevioside, rebaudioside A, rebaudioside B, rebaudioside C, rebaudioside D, rebaudioside E, rebaudioside F, dulcoside A and a combination thereof.

5. The method of claim 1 , wherein:

(a) the precursor steviol glycoside is steviol-13-O-glucoside, steviol-19-O-glucoside, rubusoside, steviol-1,2-bioside, stevioside, or rebaudioside B and/or a mixture thereof, the one or more UDP-sugar is UDP-glucose,

the steviol, the precursor steviol glycoside and/or the mixture thereof is contacted with the polypeptide capable of beta 1,2 glycosylation of the C2′ of the 13-O-glucose, the 19-O-glucose, or both the 13-O-glucose and the 19-O-glucose of the precursor steviol glycoside and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:152 and one or more of: the polypeptide of uridine 5′-diphospho (UDP) glycosyl transferase (UGT) UGT85 family, comprising the UGT85C2 polypeptide capable of glycosylating the steviol or the precursor steviol glycoside at its C-13 hydroxyl group and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:3, the polypeptide of uridine 5′-diphospho (UDP) glycosyl transferase (UGT) UGT74 family, comprising the UGT74G1 polypeptide capable of glycosylating the steviol or the precursor steviol glycoside at its C-19 carboxyl group and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:1; the polypeptide capable of beta 1,2 glycosylation of the C2′ of the 13-O-glucose, the 19-O-glucose, or both the 13-O-glucose and the 19-O-glucose of the precursor steviol glycoside and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:5; and the polypeptide capable of beta 1,3 glycosylation of the C3′ of the 13-O-glucose, the 19-O-glucose, or both the 13-O-glucose and the 19-O-glucose of the precursor steviol glycoside and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:7; and

rebaudioside A is produced upon transfer of the one or more sugar moieties from the one or more UDP-glucose to steviol, the precursor steviol glycoside, and/or the mixture thereof; or

(b) the precursor steviol glycoside is steviol-13-O-glucoside or steviol-1,2-bioside and/or a mixture thereof, the one or more UDP-sugar is UDP-glucose,

the steviol, the precursor steviol glycoside and/or the mixture thereof is contacted with the polypeptide capable of beta 1,2 glycosylation of the C2′ of the 13-O-glucose, the 19-O-glucose, or both the 13-O-glucose and the 19-O-glucose of the precursor steviol glycoside and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:152 and one or more of: the polypeptide of uridine 5′-diphospho (UDP) glycosyl transferase (UGT) UGT85 family, comprising the UGT85C2 polypeptide capable of glycosylating the steviol or the precursor steviol glycoside at its C-13 hydroxyl group and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:3, the polypeptide capable of beta 1,2 glycosylation of the C2′ of the 13-O-glucose, the 19-O-glucose, or both the 13-O-glucose and the 19-O-glucose of the precursor steviol glycoside and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:5; and the polypeptide capable of beta 1,3 glycosylation of the C3′ of the 13-O-glucose, the 19-O-glucose, or both the 13-O-glucose and the 19-O-glucose of the precursor steviol glycoside and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:7; and

rebaudioside B is produced upon transfer of the one or more sugar moieties from the one or more UDP-glucose to steviol, the precursor steviol glycoside, and/or the mixture thereof; or

(c) the precursor steviol glycoside is steviol-13-O-glucoside, steviol-19-O-glucoside, rubusoside, steviol-1,2-bioside, or stevioside and/or a mixture thereof, the one or more UDP-sugar is UDP-glucose,

the steviol, the precursor steviol glycoside and/or the mixture thereof is contacted with the polypeptide capable of beta 1,2 glycosylation of the C2′ of the 13-O-glucose, the 19-O-glucose, or both the 13-O-glucose and the 19-O-glucose of the precursor steviol glycoside and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:152 and one or more of: the polypeptide of uridine 5′-diphospho (UDP) glycosyl transferase (UGT) UGT85 family, comprising the UGT85C2 polypeptide capable of glycosylating the steviol or the precursor steviol glycoside at its C-13 hydroxyl group and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:3, the polypeptide of uridine 5′-diphospho (UDP) glycosyl transferase (UGT) UGT74 family, comprising the UGT74G1 polypeptide capable of glycosylating the steviol or the precursor steviol glycoside at its C-19 carboxyl group and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:1; the polypeptide capable of beta 1,2 glycosylation of the C2′ of the 13-O-glucose, the 19-O-glucose, or both the 13-O-glucose and the 19-O-glucose of the precursor steviol glycoside and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:5; and the polypeptide capable of beta 1,3 glycosylation of the C3′ of the 13-O-glucose, the 19-O-glucose, or both the 13-O-glucose and the 19-O-glucose of the precursor steviol glycoside and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:7; and

rebaudioside E is produced upon transfer of the one or more sugar moieties from the one or more UDP-glucose to steviol, the precursor steviol glycoside, and/or the mixture thereof; or

(d) the precursor steviol glycoside is steviol-13-O-glucoside, steviol-19-O-glucoside, rubusoside, steviol-1,2-bioside, stevioside, rebaudioside A, rebaudioside B, or rebaudioside E and/or a mixture thereof, the one or more UDP-sugar is UDP-glucose,

the steviol, the precursor steviol glycoside and/or the mixture thereof is contacted with the polypeptide capable of beta 1,2 glycosylation of the C2′ of the 13-O-glucose, the 19-O-glucose, or both the 13-O-glucose and the 19-O-glucose of the precursor steviol glycoside and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:152 and one or more of: the polypeptide of uridine 5′-diphospho (UDP) glycosyl transferase (UGT) UGT85 family, comprising the UGT85C2 polypeptide capable of glycosylating the steviol or the precursor steviol glycoside at its C-13 hydroxyl group and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:3, the polypeptide of uridine 5′-diphospho (UDP) glycosyl transferase (UGT) UGT74 family, comprising the UGT74G1 polypeptide capable of glycosylating the steviol or the precursor steviol glycoside at its C-19 carboxyl group and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:1; the polypeptide capable of beta 1,2 glycosylation of the C2′ of the 13-O-glucose, the 19-O-glucose, or both the 13-O-glucose and the 19-O-glucose of the precursor steviol glycoside and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:5; and the polypeptide capable of beta 1,3 glycosylation of the C3′ of the 13-O-glucose, the 19-O-glucose, or both the 13-O-glucose and the 19-O-glucose of the precursor steviol glycoside and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:7; and

rebaudioside D is produced upon transfer of the one or more sugar moieties from the one or more UDP-glucose to steviol, the precursor steviol glycoside, and/or the mixture thereof; or

(e) the precursor steviol glycoside is steviol-13-O-glucoside, steviol-19-O-glucoside, rubusoside, or steviol-1,2-rhamnobioside and/or a mixture thereof, the one or more UDP-sugar is UDP-glucose and UDP-rhamnose,

the steviol, the precursor steviol glycoside and/or the mixture thereof is contacted with the polypeptide capable of beta 12 glycosylation of the C2′ of the 13-O-glucose, the 19-O-glucose, or both the 13-O-glucose and the 19-O-glucose of the precursor steviol glycoside and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:152 and one or more of: the polypeptide of uridine 5′-diphospho (UDP) glycosyl transferase (UGT) UGT85 family, comprising the UGT85C2 polypeptide capable of glycosylating the steviol or the precursor steviol glycoside at its C-13 hydroxyl group and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:3, the polypeptide of uridine 5′-diphospho (UDP) glycosyl transferase (UGT) UGT74 family, comprising the UGT74G1 polypeptide capable of glycosylating the steviol or the precursor steviol glycoside at its C-19 carboxyl group and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:1; the polypeptide capable of beta 1,2 glycosylation of the C2′ of the 13-O-glucose, the 19-O-glucose, or both the 13-O-glucose and the 19-O-glucose of the precursor steviol glycoside and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:5; and the polypeptide capable of rhamnosylation of the steviol 13-O-monoside and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:150; and

dulcoside A is produced upon transfer of the one or more sugar moieties from the one or more UDP-glucose and UDP-rhamnose to steviol, the precursor steviol glycoside, and/or the mixture thereof; or

(f) the precursor steviol glycoside is steviol-13-O-glucoside, steviol-19-O-glucoside, rubusoside, steviol-1,2-rhamnobioside, or dulcoside A and/or a mixture thereof, the one or more UDP-sugar is UDP-glucose and UDP-rhamnose,

the steviol, the precursor steviol glycoside and/or the mixture thereof is contacted with the polypeptide capable of beta 12 glycosylation of the C2′ of the 13-O-glucose, the 19-O-glucose, or both the 13-O-glucose and the 19-O-glucose of the precursor steviol glycoside and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:152 and one or more of: the polypeptide of uridine 5′-diphospho (UDP) glycosyl transferase (UGT) UGT85 family, comprising the UGT85C2 polypeptide capable of glycosylating the steviol or the precursor steviol glycoside at its C-13 hydroxyl group and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:3, the polypeptide of uridine 5′-diphospho (UDP) glycosyl transferase (UGT) UGT74 family, comprising the UGT74G1 polypeptide capable of glycosylating the steviol or the precursor steviol glycoside at its C-19 carboxyl group and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:1; the polypeptide capable of beta 1,2 glycosylation of the C2′ of the 13-O-glucose, the 19-O-glucose, or both the 13-O-glucose and the 19-O-glucose of the precursor steviol glycoside and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:5; the polypeptide capable of rhamnosylation of the steviol 13-O-monoside and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:150; and the polypeptide capable of beta 1,3 glycosylation of the C3′ of the 13-O-glucose, the 19-O-glucose, or both the 13-O-glucose and the 19-O-glucose of the precursor steviol glycoside and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:7; and

rebaudioside C is produced upon transfer of the one or more sugar moieties from the one or more UDP-glucose and UDP-rhamnose to steviol, the precursor steviol glycoside, and/or the mixture thereof; or

(g) the precursor steviol glycoside is steviol-13-O-glucoside, steviol-19-O-glucoside, rubusoside, 1,2-steviolxyloside, or steviol-1,2-xylobioside, and/or a mixture thereof, the one or more UDP-sugar is UDP-glucose and UDP-xylose,

the steviol, the precursor steviol glycoside and/or the mixture thereof is contacted with the polypeptide capable of beta 12 glycosylation of the C2′ of the 13-O-glucose, the 19-O-glucose, or both the 13-O-glucose and the 19-O-glucose of the precursor steviol glycoside and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:152 and one or more of: the polypeptide of uridine 5′-diphospho (UDP) glycosyl transferase (UGT) UGT85 family, comprising the UGT85C2 polypeptide capable of glycosylating the steviol or the precursor steviol glycoside at its C-13 hydroxyl group and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:3, the polypeptide of uridine 5′-diphospho (UDP) glycosyl transferase (UGT) UGT74 family, comprising the UGT74G1 polypeptide capable of glycosylating the steviol or the precursor steviol glycoside at its C-19 carboxyl group and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:1; the polypeptide capable of beta 1,2 glycosylation of the C2′ of the 13-O-glucose, the 19-O-glucose, or both the 13-O-glucose and the 19-O-glucose of the precursor steviol glycoside and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:5; the polypeptide capable of beta 1,3 glycosylation of the C3′ of the 13-O-glucose, the 19-O-glucose, or both the 13-O-glucose and the 19-O-glucose of the precursor steviol glycoside and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:7, a UDP-glucose dehydrogenase (UGD1) polypeptide, and/or a UDP-glucuronic decarboxylase (UXS3) polypeptide; and

rebaudioside F is produced upon transfer of the one or more sugar moieties from the one or more UDP-glucose and UDP-xylose to steviol, the precursor steviol glycoside, and/or the mixture thereof; or

(h) the precursor steviol glycoside is steviol-13-O-glucoside, the one or more UDP-sugar is UDP-glucose,

the steviol, the precursor steviol glycoside and/or the mixture thereof is contacted with the polypeptide capable of beta 12 glycosylation of the C2′ of the 13-O-glucose, the 19-O-glucose, or both the 13-O-glucose and the 19-O-glucose of the precursor steviol glycoside and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:152 and one or more of: the polypeptide of uridine 5′-diphospho (UDP) glycosyl transferase (UGT) UGT85 family, comprising the UGT85C2 polypeptide capable of glycosylating the steviol or the precursor steviol glycoside at its C-13 hydroxyl group and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:3, the polypeptide of uridine 5′-diphospho (UDP) glycosyl transferase (UGT) UGT74 family, comprising the UGT74G1 polypeptide capable of glycosylating the steviol or the precursor steviol glycoside at its C-19 carboxyl group and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:1; and the polypeptide capable of beta 1,2 glycosylation of the C2′ of the 13-O-glucose, the 19-O-glucose, or both the 13-O-glucose and the 19-O-glucose of the precursor steviol glycoside and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:5; and

steviol-1,2-bioside is produced upon transfer of the one or more sugar moieties from the one or more UDP-glucose to steviol, the precursor steviol glycoside, and/or the mixture thereof; or

(i) the precursor steviol glycoside is steviol-13-O-glucoside, steviol-19-O-glucoside, steviol-1,2-bioside, or rubusoside, and/or a mixture thereof, the one or more UDP-sugar is UDP-glucose,

the steviol, the precursor steviol glycoside and/or the mixture thereof is contacted with the polypeptide capable of beta 1,2 glycosylation of the C2′ of the 13-O-glucose, the 19-O-glucose, or both the 13-O-glucose and the 19-O-glucose of the precursor steviol glycoside and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:152 and one or more of: the polypeptide of uridine 5′-diphospho (UDP) glycosyl transferase (UGT) UGT85 family, comprising the UGT85C2 polypeptide capable of glycosylating the steviol or the precursor steviol glycoside at its C-13 hydroxyl group and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:3, the polypeptide of uridine 5′-diphospho (UDP) glycosyl transferase (UGT) UGT74 family, comprising the UGT74G1 polypeptide capable of glycosylating the steviol or the precursor steviol glycoside at its C-19 carboxyl group and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:1; the polypeptide capable of beta 1,2 glycosylation of the C2′ of the 13-O-glucose, the 19-O-glucose, or both the 13-O-glucose and the 19-O-glucose of the precursor steviol glycoside and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:5; and the polypeptide capable of beta 1,3 glycosylation of the C3′ of the 13-O-glucose, the 19-O-glucose, or both the 13-O-glucose and the 19-O-glucose of the precursor steviol glycoside and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:7; and

stevioside is produced upon transfer of the one or more sugar moieties from the one or more UDP-glucose to steviol, the precursor steviol glycoside, and/or the mixture thereof.

6. The method of claim 1 , wherein the target steviol glycoside or the target steviol glycoside composition is produced in a recombinant host cell which has been transformed with a gene encoding the first polypeptide capable of beta 1,2 glycosylation of the C2′ of the 13-O-glucose, the 19-O-glucose, or both the 13-O-glucose and the 19-O-glucose of the precursor steviol glycoside and having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:152.

7. The method of claim 1 , wherein the method is an in vitro method, further comprising supplying the one or more UDP-sugars or supplying a cell-free system for regeneration of the one or more UDP-sugars.

8. The method of claim 7 , wherein the in vitro method is an enzymatic in vitro method or a whole cell in vitro method.

9. The method of claim 8 , wherein the whole cell in vitro method comprises feeding raw materials comprising Stevia extracts, comprising the one or more UDP-sugars and one or more of the steviol, the precursor steviol glycoside and/or the mixture thereof to a whole cell.

10. The method of claim 9 , wherein the whole cell used in the whole cell in vitro method has a reduced ability to degrade external sucrose.

11. The method of claim 9 , wherein an endogenous sucrose invertase of the whole cell comprising the in vitro method is disrupted.

12. The method of claim 9 , further comprising feeding raw materials during or after cell growth.

13. The method of claim 9 , wherein the whole cell used in the whole cell in vitro method is:

(a) in suspension or immobilized;

(b) entrapped in a calcium or sodium alginate bead;

(c) linked to a hollow fiber tube reactor system;

(d) concentrated and entrapped within a membrane reactor system; or

(e) in fermentation broth or in a reaction buffer.

14. The method of claim 9 , further comprising permeabilizing the whole cell by using a permeabilizing agent, wherein the permeabilizing agent is a solvent, a detergent, or a surfactant, by a mechanical shock, an electroporation, or an osmotic shock.

15. The method of claim 9 , wherein the whole cell used in the whole cell in vitro method is a plant cell, a mammalian cell, an insect cell, a fungal cell from Aspergillus genus or a yeast cell from Saccharomyces cerevisiae, Schizosaccharomyces pombe, Yarrowia lipolytica, Candida glabrata, Ashbya gossypii, Cyberlindnera jadinii, Pichia pastoris, Kluyveromyces lactis, Hansenula polymorpha, Candida boidinii, Arxula adeninivorans, Xanthophyllomyces dendrorhous , or Candida albicans species, an algal cell or a bacterial cell from Escherichia coli species or Bacillus genus.

16. The method of claim 1 , wherein:

(a) the second polypeptide capable of beta 1,2 glycosylation of the C2′ of the 13-O-glucose, the 19-O-glucose, or both the 13-O-glucose and the 19-O-glucose of the precursor steviol glycoside comprises:

(i) a polypeptide having an arginine at residue 206, a cysteine at residue 207, and an arginine at residue 343 of SEQ ID NO:5;

(ii) a polypeptide having a tyrosine or phenylalanine at residue 30, a proline or glutamine at residue 93, a serine or valine at residue 99, a tyrosine or a phenylalanine at residue 122, a histidine or tyrosine at residue 140, a serine or cysteine at residue 142, an alanine or threonine at residue 148, a methionine at residue 152, an alanine at residue 153, an alanine or serine at residue 156, a glycine at residue 162, a leucine or methionine at residue 195, a glutamic acid at residue 196, a lysine or glutamic acid at residue 199, a leucine or methionine at residue 211, a leucine at residue 213, a serine or phenylalanine at residue 221, a valine or isoleucine at residue 253, a valine or alanine at residue 286, a lysine or asparagine at residue 427, an alanine at residue 438, and either an alanine or threonine at residue 462 of SEQ ID NO:5;

(iii) a polypeptide having a methionine at residue 211 and an alanine at residue 286 of SEQ ID NO:5; or

(iv) a polypeptide having at least 90% sequence identity to any one of the amino acid sequences set forth in SEQ ID NOs:10, 12, or 95; and

(b) the polypeptide capable of glycosylating the steviol or the precursor steviol glycoside at its C-13 hydroxyl group comprises a polypeptide having one or more amino acid substitutions at residues K9E, K10R, V13F, F15L, Q21H, M27V, H60D, A65S, E71Q, 187F, L91P, K220T, R243W, T270M, T270R, Q289H, Y298C, L334S, K350T, H368R, A389V, 1394V, P397S, E418V, G420R, L431P, G440D, H441N, R444G, and M471 of SEQ ID NO:3;

and/or

(c) the polypeptide capable of beta 1,3 glycosylation of the C3′ of the 13-O-glucose, the 19-O-glucose, or both the 13-O-glucose and the 19-O-glucose of the precursor steviol glycoside comprises a polypeptide having one or more amino acid substitutions at residues M291, V74E, V87G, L91P, G116E, A123T, Q125A, 1126L, T130A, V145M, C192S, S193A, F194Y, M196N, K198Q, K1991, Y200L, Y2031, F204L, E205G, N206K, 1207M, T2081, P266Q, S273P, R274S, G284T, T285S, L330V, G331A, and L346I of SEQ ID NO:7.

Assignments (2)
MERGER Recorded Jun 18, 2024
From: EVOLVA AG
To: DANSTAR FERMENT AG
Reel/Frame 067762/0086 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2017
From: HOUGHTON-LARSEN, JENS; HANSEN, JORGEN; MIKKELSEN DALGAARD, MICHAEL; HALKJAER HANSEN, ESBEN
To: EVOLVA SA
Reel/Frame 043058/0070 →
Continuity (8)
Division 14237540
Provisional Application 61521084 · Aug 8, 2011
Provisional Application 61521203 · Aug 8, 2011
Provisional Application 61521051 · Aug 8, 2011
Provisional Application 61523487 · Aug 15, 2011
Provisional Application 61567929 · Dec 7, 2011
Provisional Application 61603639 · Feb 27, 2012
Related Publication 20170321238A1 · Nov 9, 2017
Cited By (1)
US 12,416,034